Send the following on WhatsApp
Continue to Chathttps://nl.marketscreener.com/koers/aandeel/APTOSE-BIOSCIENCES-INC-1410675/nieuws/Aptose-Biosciences-Inc-kondigt-de-monotherapiedosering-van-120-Mg-aan-voor-patienten-in-de-Aptivat-42855382/?utm_source=whatsapp&utm_medium=social&utm_campaign=share